Cambridge News reports on a new study that suggests certain type 2 diabetes medications may in fact be doing the very thing they’re supposed to prevent. The study, published last week in the Journal of Biological Chemistry, says drugs belonging to the glucagon-like peptide-1 (GLP-1) agonist class, such as AstraZeneca’s Byetta, “may actually release sugar into the blood.” The findings are problematic, considering high blood sugar is ...
Study Says Byetta, Other GLP-1 Agonists May Release Sugar into Blood
Posted October 7, 2015 in Byetta/Januvia Pancreatic Cancer | Product News and Recalls
L.A. Court Grants Motion to Unseal Images from Byetta Study
Posted August 5, 2015 in Byetta/Januvia Pancreatic Cancer | Product News and Recalls
The Superior Court of California for the District of Los Angeles has granted Byetta plaintiffs’ motion to unseal images from a 273-day monkey study conducted by Amylin Pharmaceuticals, a subsidiary of AstraZeneca. According to a court document, the ruling was made at a July 9 status conference.
Byetta is a widely prescribed type 2 diabetes medication belonging to the incretin mimetic class of drugs. Despite its popularity, Byetta has been the ...
continue reading...Do I Have a Byetta Claim?
Posted September 8, 2014 in Byetta/Januvia Pancreatic Cancer | Product News and Recalls
Many Americans who were diagnosed with pancreatic cancer or thyroid cancer while taking the prescription medication Byetta may wonder if they can file a Byetta lawsuit and recover for their injuries. Whether you have a claim and how much your case may be worth will depend on the specific details of your experience. You should consult with an attorney who can evaluate whether you have a viable products liability claim.
What is Byetta?
Byetta is an injectable medicine ...
How Much Time Do I Have to File a Byetta Case?
Posted July 14, 2014 in Byetta/Januvia Pancreatic Cancer | Product News and Recalls
Thousands of people around the country have been injured by the prescription drug Byetta. Byetta, generically known as exanatide, is a drug used to treat type 2 diabetes. Originally manufactured by Eli Lilly and Company and Amylin Pharmaceuticals, Byetta is now manufactured by Bristol-Myers Squibb after its 2012 acquisition of Amylin. The drug is an injectable medication that can improve blood sugar control in adults who have type 2 diabetes.
Recent data has linked the use ...
continue reading...Has Byetta Been Recalled?
Posted June 23, 2014 in Byetta/Januvia Pancreatic Cancer | Product News and Recalls
Despite many calls to action from public consumer groups, the Food and Drug Administration (FDA) has so far declined to require a recall of the drug Byetta.
What Are the Risks of Byetta?
Byetta is an injectable medicine prescribed to control the high blood sugar in millions of diabetic patients. However, medical research has shown that Byetta increases a person’s risks of the following dangerous medical conditions:
- Pancreatitis;
- Kidney failure;
- Pancreatic cancer; and
- Thyroid cancer.
In 2007, six Byetta-related deaths ...
continue reading...What Are Januvia Side Effects?
Posted May 2, 2014 in Byetta/Januvia Pancreatic Cancer | Product News and Recalls
Januvia is a once-a-day prescription medication used to lower blood sugar levels in patients with type 2 diabetes. While there are many medications for people with diabeties, some, like Januvia may cause serious side effects.
Like most prescriptions, Januvia’s side effects can be mild and inconvenient for patients, such as nausea, headache, sore throat, and more. However, recent medical studies have found that patients taking Januvia have experienced much more severe and possibly life-threatening side effects that are not ...
continue reading...
